The miR-200 microRNA family suppresses the epithelial–mesenchymal transition (EMT) to promote the reverse process, MET; however, there are conflicting reports on its role in metastasis. Korpal et al. (Nature Med. 17, 1101–1108; 2011) now show that miR-200 microRNAs promote metastatic colonization by regulating the tumour cell secretome.
Analysis of human breast tumour and lung metastasis samples as well as cancer cell lines correlated miR-200 expression with metastatic potential and poor distant relapse-free survival. miR-200 overexpression reduced entry of tumour cells into the circulation of mice, potentially by inhibiting EMT, but increased the lung-colonization ability of poorly metastatic cancer cell lines. This was not phenocopied by overexpresion of E-cadherin, a known MET-mediator upregulated by miR-200. Gene expression and mass-spectrometry analyses identified Sec23a, a secretory pathway component, as a miR-200 target, and Sec23a depletion, similarly to miR-200 overexpression, suppressed metastatic colonization. Mass-spectrometry analysis of conditioned media from Sec23a-depleted tumour cells revealed reduced secretion of a protein set, the low expression of which correlated with low relapse-free survival. Depletion of two such factors, Igfbp4 and Tinagl1, increased metastatic colonization implicating them in metastasis suppression.
These findings indicate that although miR-200 microRNAs may suppress EMT and early tumour cell dissemination, they promote metastatic colonization of cells that successfully enter the circulation by inhibiting secretion of metastasis suppressors.
Rights and permissions
About this article
Cite this article
Zaromytidou, AI. Regulating metastasis: The two faces of miR-200. Nat Cell Biol 13, 1294 (2011). https://doi.org/10.1038/ncb2379
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2379